Composition
- Active ingredients
- RILUZOLE 50MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RILUZOLE 50MG · TabletANDA203042-001 · Discontinued
- RILUZOLE 50MG · TabletANDA206045-001 · Prescription
- RILUZOLE 50MG · TabletANDA091300-001 · Discontinued
- RILUZOLE 50MG · TabletANDA091417-001 · Discontinued
- RILUZOLE 50MG · TabletANDA076173-001 · Prescription
- RILUZOLE 50MG · TabletANDA204048-001 · Prescription
- RILUZOLE 50MG · TabletThis page
- RILUZOLE 50MG · TabletANDA091394-001 · Prescription
- RILUZOLE 50MG/10ML · SuspensionANDA216035-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA204430.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Riluzole
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Daito Pharms Co LTD
- Status
- Discontinued
- FDA approval
- 16 Oct 2018
- Application
- ANDA204430-001



